Metabolic phenotype of skeletal muscle in early critical illness
- 1 October 2018
- Vol. 73 (10), 926-935
- https://doi.org/10.1136/thoraxjnl-2017-211073
Abstract
Objectives To characterise the sketetal muscle metabolic phenotype during early critical illness. Methods Vastus lateralis muscle biopsies and serum samples (days 1 and 7) were obtained from 63 intensive care patients (59% male, 54.7 +/- 18.0 years, Acute Physiology and Chronic Health Evaluation II score 23.5 +/- 6.5). Measurements and main results From day 1 to 7, there was a reduction in mitochondrial beta-oxidation enzyme concentrations, mitochondrial biogenesis markers (PGC1 alpha messenger mRNA expression (-27.4CN (95% CI -123.9 to 14.3); n=23; p=0.025) and mitochondria' DNA copy number (-1859CN (IQR -5557-1325); n=35; p=0.032). Intramuscular ATP content was reduced compared tocompared with controls on day 1 (17.7mmol/kg/dry weight (dw) (95% CI 15.3 to 20.0) vs. 21.7 mmol/kg Idw (95% CI 20.4 to 22.9); p<0.001) and decreased over 7 days (-4.8 mmol/kg dw (IQR 8.0-1.2); n=33; p=0.001). In addition, the ratio of phosphorylated:total AMP-K (the hioenergetic sensor) increased (0.52 (IQR 0.09-2.6); n=31; p<0.001). There was an increase in intramuscular phosphocholine (847.2AU (IQR 232.5-1672); n=15; p=0.022), intramuscular tumour necrosis factor receptor 1 (0.66 pg (IQR -0.44-3.33); n=29; p=0.041) and IL-10 (13.6 ng (IQR 3.4-39.0); n=29; p=0.004). Serum adiponectin (10.3 mu g (95% CI 6.8 to 13.7); p<0.001) and ghrelin (16.0 ng/mL (IQR 7-100); p=0.028) increased. Network analysis revealed a close and direct relationship between bioenergetic impairment and reduction in muscle mass and between intramuscular inflammation and impaired anabolic signaling. ATP content and muscle mass were unrelated to lipids delivered. Conclusions Decreased mitochondrial biogenesis and dysregulated lipid oxidation contribute to compromised skeletal muscle hioenergetic status. In addition, intramuscular inflammation was associated with impaired anabolic recovery with lipid delivery observed as bioenergetically inert. Future clinical work will focus on these key areas to ameliorate acute skeletal muscle wasting.Keywords
Funding Information
- Wellcome Trust
- European Society of Intensive Care Medicine
- National Institute of Health Research
- Whittington Hospital NHS Trust
- Guy’s & St Thomas' and King’s College London NIHR Comprehensive Biomedical Research Centre
This publication has 55 references indexed in Scilit:
- Principled missing data methods for researchersSpringerPlus, 2013
- Macrophage polarization in metabolic disordersCurrent Opinion in Lipidology, 2011
- Novel events in the molecular regulation of muscle mass in critically ill patientsThe Journal of Physiology, 2011
- Interleukin-10 reduces the pathology of mdx muscular dystrophy by deactivating M1 macrophages and modulating macrophage phenotypeHuman Molecular Genetics, 2010
- Survival in Critical Illness Is Associated with Early Activation of Mitochondrial BiogenesisAmerican Journal of Respiratory and Critical Care Medicine, 2010
- Low‐dose dexamethasone prevents endotoxaemia‐induced muscle protein loss and impairment of carbohydrate oxidation in rat skeletal muscleThe Journal of Physiology, 2010
- A potential role for Akt/FOXO signalling in both protein loss and the impairment of muscle carbohydrate oxidation during sepsis in rodent skeletal muscleThe Journal of Physiology, 2008
- Adiponectin as an anti-inflammatory factorClinica Chimica Acta; International Journal of Clinical Chemistry, 2007
- Hypoxia Inhibits Protein Synthesis through a 4E-BP1 and Elongation Factor 2 Kinase Pathway Controlled by mTOR and Uncoupled in Breast Cancer CellsMolecular and Cellular Biology, 2006
- Cytoscape: A Software Environment for Integrated Models of Biomolecular Interaction NetworksGenome Research, 2003